Imagin Medical Logo
CA45250L2049
A2QEY3
IMEXF

Imagin Medical

Loading quotes...

Forecast

There is no analyst data available for this company.

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics
In 2022, Imagin Medical has already paid +42,76 in dividends. The last payout was in June 2022.

Financials

In the last year, Imagin Medical had revenue of 0.00 and net profit of 1.84m
(EUR) 2022
YoY
Revenue 0.00 -
Gross profit 34.75k 73,64%
Net profit 1.84m 76,48%
EBITDA 2.51m 8,96%

Fundamentals

Metric Value
Market capitalization
+929.38
Number of shares
10.83m
52-week high/low
+0,00944 - +0,0000858
Dividends No
Beta
1,59
P/E ratio
0,00
PEG ratio
0,00
P/B ratio
0,00
P/S ratio
0,00

Company profile

Imagin Medical Inc. ist ein Unternehmen für chirurgische Bildgebung mit Schwerpunkt auf Blasenkrebs. Das Unternehmen entwickelt das i/Blue Imaging System, um den Bedarf von Urologen an BLC zu decken. Imagin Medical Inc. wurde 1986 gegründet und hat seinen Hauptsitz in Vancouver, Kanada.

Name
Imagin Medical
CEO
E. James Hutchens
Headquarters Vancouver, bc
Canada
Website
IPO
01/23/2013
Employees 10

Ticker symbols

Exchange Symbol
Pnk
IMEXF
Frankfurt
DPD3.F
München
DPD3.MU
🍪

Parqet  uses cookies. Learn more